Disposition of linezolid or daptomycin in Enterococcal bloodstream infections according to vancomycin resistant Enterococcus colonization
| Autor: | Jeannie Ong, Elizabeth Short, John S. Esterly, Milena M. McLaughlin, Michael Postelnick |
|---|---|
| Rok vydání: | 2014 |
| Předmět: |
Microbiology (medical)
medicine.medical_specialty medicine.drug_class VRE Antibiotics Drug resistance medicine.disease_cause chemistry.chemical_compound Daptomycin Internal medicine Medicine Pharmacology (medical) Vancomycin-resistant Enterococcus Letter to the Editor biology business.industry Public Health Environmental and Occupational Health Linezolid Retrospective cohort study biochemical phenomena metabolism and nutrition biology.organism_classification bacterial infections and mycoses digestive system diseases De-escalation Surgery Infectious Diseases chemistry Enterococcus business Empiric therapy medicine.drug |
| Zdroj: | Antimicrobial Resistance and Infection Control |
| ISSN: | 2047-2994 |
| Popis: | Vancomycin resistant Enterococcus (VRE) colonized patients are likely to receive VRE targeted Gram-positive antibiotics and may not be de-escalated appropriately once final cultures are available. A retrospective cohort study was conducted in VRE-colonized and non-VRE colonized patients with Enterococcal bloodstream infections. Of 101 patients (n = 50 VRE-colonized; n = 51 non-colonized), empiric therapy with linezolid or daptomycin was started more often in VRE-colonized than non-colonized patients (n = 8, 15.5% vs n = 27, 54%, p |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink